These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 19077687)
41. Intrarenal formation of angiotensin II. Navar LG; Nishiyama A Contrib Nephrol; 2001; (135):1-15. PubMed ID: 11705276 [No Abstract] [Full Text] [Related]
42. Regulation of apoptosis by angiotensin II in the heart and lungs (Review). Filippatos G; Tilak M; Pinillos H; Uhal BD Int J Mol Med; 2001 Mar; 7(3):273-80. PubMed ID: 11179507 [TBL] [Abstract][Full Text] [Related]
43. Role of the Renin-Angiotensin System Components in Renal Cell Carcinoma: A Literature Review. Mourão TC; Bezerra SM; Santos VE; Brazão ES; da Costa WH; Zequi SC Curr Urol Rep; 2023 Jul; 24(7):345-353. PubMed ID: 37074633 [TBL] [Abstract][Full Text] [Related]
44. Angiotensin (1-12) in Humans With Normal Blood Pressure and Primary Hypertension. Ferrario CM; Iyer SR; Burnett JC; Ahmad S; Wright KN; VonCannon JL; Saha A; Groban L Hypertension; 2021 Mar; 77(3):882-890. PubMed ID: 33461312 [TBL] [Abstract][Full Text] [Related]
45. Rapeseed protein-derived peptides, LY, RALP, and GHS, modulates key enzymes and intermediate products of renin-angiotensin system pathway in spontaneously hypertensive rat. He R; Yang YJ; Wang Z; Xing CR; Yuan J; Wang LF; Udenigwe C; Ju XR NPJ Sci Food; 2019; 3():1. PubMed ID: 31304273 [TBL] [Abstract][Full Text] [Related]
46. Calcimimetic R568 improved cardiac remodeling by classic and novel renin-angiotensin system in spontaneously hypertensive rats. Zhang T; Tang N; Xi D; Zhao Y; Liu Y; Wang L; Tang Y; Zhang X; Zhong H; He F Exp Biol Med (Maywood); 2019 Jul; 244(10):789-801. PubMed ID: 31159562 [TBL] [Abstract][Full Text] [Related]
47. Mitochondrial angiotensin receptors and cardioprotective pathways. Escobales N; Nuñez RE; Javadov S Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1426-H1438. PubMed ID: 30978131 [TBL] [Abstract][Full Text] [Related]
48. Intracrine action of angiotensin II in mesangial cells: subcellular distribution of angiotensin II receptor subtypes AT da Silva Novaes A; Ribeiro RS; Pereira LG; Borges FT; Boim MA Mol Cell Biochem; 2018 Nov; 448(1-2):265-274. PubMed ID: 29455433 [TBL] [Abstract][Full Text] [Related]
49. Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme. Ahmad S; Varagic J; VonCannon JL; Groban L; Collawn JF; Dell'Italia LJ; Ferrario CM Biochem Biophys Res Commun; 2016 Sep; 478(2):559-64. PubMed ID: 27465904 [TBL] [Abstract][Full Text] [Related]
50. Intracrine angiotensin II functions originate from noncanonical pathways in the human heart. Ferrario CM; Ahmad S; Varagic J; Cheng CP; Groban L; Wang H; Collawn JF; Dell Italia LJ Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H404-14. PubMed ID: 27233763 [TBL] [Abstract][Full Text] [Related]
51. Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice. Zhang Y; Wang L; Song Y; Zhao X; Wong MS; Zhang W Osteoporos Int; 2016 Mar; 27(3):1083-1092. PubMed ID: 26439241 [TBL] [Abstract][Full Text] [Related]
52. International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. Karnik SS; Unal H; Kemp JR; Tirupula KC; Eguchi S; Vanderheyden PM; Thomas WG Pharmacol Rev; 2015 Oct; 67(4):754-819. PubMed ID: 26315714 [TBL] [Abstract][Full Text] [Related]
53. Renin-angiotensin system in the kidney: What is new? Ferrão FM; Lara LS; Lowe J World J Nephrol; 2014 Aug; 3(3):64-76. PubMed ID: 25332897 [TBL] [Abstract][Full Text] [Related]
54. An evolving story of angiotensin-II-forming pathways in rodents and humans. Ferrario CM; Ahmad S; Nagata S; Simington SW; Varagic J; Kon N; Dell'italia LJ Clin Sci (Lond); 2014 Apr; 126(7):461-9. PubMed ID: 24329563 [TBL] [Abstract][Full Text] [Related]
55. Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis. Ma KL; Ni J; Wang CX; Liu J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC Int J Med Sci; 2013; 10(12):1615-24. PubMed ID: 24151433 [TBL] [Abstract][Full Text] [Related]
56. Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cells. Ni J; Ma KL; Wang CX; Liu J; Zhang Y; Lv LL; Ni HF; Chen YX; Ruan XZ; Liu BC Lipids Health Dis; 2013 Apr; 12():49. PubMed ID: 23570453 [TBL] [Abstract][Full Text] [Related]
57. Intracellular Enhanced Cyan Fluorescent Protein/Angiotensin II Does Not Modify Angiotensinogen Accumulation in Transgenic Mice. Singh A; Vitko J; Re RN; Cook JL Ochsner J; 2013; 13(1):37-41. PubMed ID: 23532622 [TBL] [Abstract][Full Text] [Related]
58. Direct evidence for intrarenal chymase-dependent angiotensin II formation on the diabetic renal microvasculature. Park S; Bivona BJ; Ford SM; Xu S; Kobori H; de Garavilla L; Harrison-Bernard LM Hypertension; 2013 Feb; 61(2):465-71. PubMed ID: 23213190 [TBL] [Abstract][Full Text] [Related]
59. The intracrine renin-angiotensin system. Kumar R; Thomas CM; Yong QC; Chen W; Baker KM Clin Sci (Lond); 2012 Sep; 123(5):273-84. PubMed ID: 22590974 [TBL] [Abstract][Full Text] [Related]
60. Intracardiac intracellular angiotensin system in diabetes. Kumar R; Yong QC; Thomas CM; Baker KM Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(5):R510-7. PubMed ID: 22170614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]